Fig. 1
From: MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
Relative MYO18B expression in tumor tissues and its clinical significance. a MYO18B was over-expressed in tumor tissues (n = 374) compared with normal tissues (n = 50), which was analyzed using TCGA database. b MYO18B was up-regulated in tumor tissues (n = 80) compared with adjacent liver tissues (ALT), which was analyzed by qRT-PCR. c Kaplan-Meier survival analysis showed that MYO18B over-expression was correlated with worse overall survival in patients with hepatocellular carcinoma (P = 0.001)